Children and Adolescent Psychopharmacology

Children and Adolescent Psychopharmacology 

According to the National Institute of Mental Health, children and adolescents handle medications differently than adults. The brains and bodies of children and adolescents are still growing and developing in complexity, and the younger the child, the more development still has to take place. Children’s livers, kidneys, and gastrointestinal tracts, which are involved in metabolizing medications, may also be at different levels of development and functioning in comparison to adults. Most medications were originally developed to treat mental health disorders in adults. Due to ethical concerns over testing the medications in children, most psychiatric medications have not undergone the rigorous testing necessary to gain FDA approval for specific age groups, diagnoses, and symptoms. Children are considered more vulnerable than adults and require parental or guardian consent to receive prescriptions as well as to enroll in clinical pharmaceutical research. Therefore, it tends to be more difficult and costly for drug companies to obtain approval for specific medications to treat the various mental health disorders and symptoms. Despite the relatively few medications with FDA approval, many medications are used to treat child and adolescent mental health disorders. When medications are prescribed for specific indications for which they have not received FDA approval, this is called “off-label prescribing.” Many of the medications used to treat child and adolescent mental health conditions are prescribed off label. Through research, scientists continue to learn the specific needs and precautions to take when treating children and adolescents. Some younger individuals may be more comfortable speaking with a mental health professional about their medications and any side effects, rather than the person who prescribed their medication. Hence, as a mental health professional, it is important for you to be familiar with child and adolescent psychopharmacology. By having some familiarity with the medications that are used in youth and their potential side effects, you will be able to help clients and their guardians understand when to approach the provider with concerns and how to discuss those concerns. This course covers a variety of psychiatric medications, including antipsychotics, stimulants, mood stabilizers, and others. You will learn about the unique issues surrounding psychopharmacology for pediatric populations, including common uses, side effects, and timelines for medication response.

$20.00

Hours: 2.00
REL-BHC-0-CAP

Certificates

Certificates provided by accrediting body (29 Match)

American Psychological Association

2.0 HOURS


Relias, LLC is approved by the American Psychological Association to sponsor continuing education for psychologists. Relias, LLC maintains responsibility for this program and its content.

California Board of Registered Nursing

2.0 HOURS


Provider approved by the California Board of Registered Nursing, CEP# 13791

Nurses will receive 2.00 contact hours for participating in this course.

American Nurses Credentialing Center

2.0 HOURS


Relias, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses will receive 2.00 contact hours for participating in this course.

Association of Social Work Boards

2.0 HOURS


Relias, LLC, #1273, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Relias LLC maintains responsibility for this course. ACE provider approval period: 02/10/2018-02/10/2021.

Course Delivery Format: Asynchronous Distance Learning-interaction includes quizzes with questions and answers, post-tests. This module is Reading-Based.

Social workers completing this course receive 2.00 Clinical continuing education clock hours.

Accreditation Council for Continuing Medical Education

2.0 HOURS


Relias LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Relias LLC designates this enduring material activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling

2.0 HOURS


Provider #50-290 This activity is approved for 2.00 contact hours.

Ohio Social Worker Board

2.0 HOURS


Provider # RST050401 290 This activity is approved for 2.00 contact hours.

New York State Education Department, Office of the Professions, Division of Professional Licensing Services, Social Work Unit

2.0 HOURS


Relias, LLC is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0009.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of licensed master social work and licensed clinical social work in New York. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice for an LMSW and LCSW. A licensee who practices beyond the authorized scope of practice could be charged with unprofessional conduct under the Education Law and Regents Rules.

As a provider of online, asynchronous education, some courses offered by Relias Learning are considered “self-study” under section 74.10(c)(2)(ii)(b)(4) of the Commissioner’s Regulations. The regulations limit self-study activities taken from a provider approved by the Education Department to no more than 12 hours in the 36-month registration period or one-third of the hours in a registration period other than 36 months.

Social workers will receive 2.00 continuing education hours for participating in this course. This activity is approved for 2.00 contact hours.

South Carolina Board of Social Work Examiners

2.0 HOURS


South Carolina Board of Social Work Examiners (CEBroker Provider 50-290)

District of Columbia Board of Nursing

2.0 HOURS


DC-RN -- District of Columbia Board of Nursing Approved Continuing Education program (CE Provider #50-290).

Nurses will receive 2.00 contact hours for participating in this course.

Florida Board of Nursing

2.0 HOURS


Florida Board of Nursing CE Provider #: 50-290

Nurses will receive 2.00 contact hours for participating in this course.

Georgia Board of Nursing

2.0 HOURS


Georgia Board of Nursing CE Provider #: 50-290

Nurses will receive 2.00 contact hours for participating in this course.

South Carolina Board of Nursing

2.0 HOURS


This program was approved by the South Carolina Board of Nursing Approved Continuing Education Program (CE provider #50-290) CE Broker Course # 20-[Custom_Code]

West Virginia Board of Registered Nursing

2.0 HOURS


New Mexico Board of Nursing

2.0 HOURS


New Mexico Board of Nursing (CEBroker Provider # 50-290)

This course awards 2.00 contact hours upon successful completion.

Arkansas State Board of Nursing

2.0 HOURS


Florida Board of Medicine

2.0 HOURS


Florida Board of Medicine CE Provider #: 50-290

Ohio State Medical Board

2.0 HOURS


State Medical Board of Ohio CE Provider #: 50-290

Louisiana State Board of Medical Examiners

2.0 HOURS


Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)

Mississippi State Board of Medical Licensure

2.0 HOURS


Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)

Florida Board of Psychology

2.0 HOURS


Florida Physician Assistants

2.0 HOURS


Illinois Professional Counselor/Clinical Counselor

2.0 HOURS


This activity is approved for 2.00 contact hours.

Illinois, Department of Financial and Professional Regulation, Marriage and Family Therapist Continuing Education Sponsor

2.0 HOURS


This activity is approved for 2.00 contact hours.

National Board for Certified Counselors

1.75 HOURS







Relias, LLC has been approved by NBCC as an Approved Continuing Education Provider, ACEP No.6110. Programs that do not qualify for NBCC credit are clearly identified. Relias , LLC is solely responsible for all aspects of the programs. This activity is approved for 1.75 contact hours

Ohio Marriage and Family Therapist Board

2.0 HOURS


CE Provider #RTX050401 for Marriage and Family Therapists:State of Ohio Counselor , Social Worker, and Marriage and Family Therapist Board.
CEBroker Provider 50- 290.

Ohio Professional Counselor Board

2.0 HOURS


Provider # RCX100502 290
This activity is approved for 2.00 contact hours.

New York State Education Department, Office of the Professions, State Board for Mental Health Practitioners, Mental Health Counselors (MHC)

2.0 HOURS


Relias, LLC, is recognized by New York State Education Department's State Board for Mental Health Practitioners as an approved provider of continuing education for licensed mental health counselors. #MHC-0011

As a provider of online, asynchronous education, some courses offered by Relias, LLC are considered "self-study". The regulations limit self-study activities taken from a provider approved by the Education Department to no more than 12 hours in the 36-month registration period or one-third of the hours in a registration period other than 36 months.

This activity is approved for 2.00 contact hours.

New York State Education Department, Office of the Professions, State Board for Mental Health Practitioners, Marriage and Family Therapists (MFT)

2.0 HOURS


Relias, LLC, is recognized by New York State Education Department's State Board for Mental Health Practitioners as an approved provider of continuing education for Licensed Marriage and Family Therapists. #MFT-0009

As a provider of online, asynchronous education, some courses offered by Relias are considered "self-study". The regulations limit self-study activities taken from a provider approved by the Education Department to no more than 12 hours in the 36-month registration period or one-third of the hours in a registration period other than 36 months.

This activity is approved for 2.00 contact hours.

Course Details

Course Code: REL-BHC-0-CAP
Hours: 2
Type: Online Course
Content Expiration Date: 10/31/2022
Learning Objectives:
Describe the different classes of psychotropic medications used to treat childhood and adolescent psychiatric disorders.
Discuss the uses and side effects of psychotropic medications commonly prescribed for psychiatric disorders in children and adolescents.
Identify at least three examples of information that should be reported to the prescribing provider when working with a child/adolescent taking psychiatric medications.

Outline:
Section 1: Introduction

About This Course

Learning Objectives

Section 2: Antidepressants

Meet Jenny

Overview of Antidepressants

Overview of the SSRIs

Adverse Effects of the SSRIs

Additional Adverse Effects of the SSRIs

FDA Black Box Warning

More About SSRIs

Tricyclic Antidepressants

Monoamine Oxidase Inhibitors

Other Antidepressants

Diagnosing Depression/Anxiety in Children and Adolescents

Review

Meet Michelle

Summary

Section 3: ADHD Medications

Overview

Specific Information about Stimulants

Adverse Effects

Stimulants and Tic Disorders

Risk for Cardiac Problems

ADHD, Stimulants, Bipolar Disorder, and Psychosis

Stimulants and Addiction

Other Medications for ADHD

Guanfacine and Clonidine

Review

Summary

Section 4: Antipsychotics and Mood Stabilizers

Overview of Antipsychotics

Adverse Effects

Specific Information about Each Antipsychotic

Recent Atypical Antipsychotic Medications

Diagnosing Bipolar Disorder in Children and Adolescents

Disruptive Mood Dysregulation Disorder

Overview of Mood Stabilizers

Specific Information about Each Mood Stabilizer

Meet Robert

Summary

Section 5: Other Medications

Diphenhydramine and Hydroxyzine 

Trazodone

Buspirone

Benzodiazepines

Medications for Tics

Sleep Difficulties

Enuresis

Review

Summary

Section 6: Conclusion

Summary

Course Contributors

Resources

References

Congratulations!

Exam and BrainSparks

Expert Reviewer: Ujjwal Ramtekkar, MD, MPE, MBA
Dr. Ramtekkar is a child and adolescent psychiatrist and distinguished fellow of American Academy of Child and Adolescent Psychiatry (AACAP). Dr. Ramtekkar has published several articles and book chapters on several topics in psychiatry including ADHD, autism, psychopharmacology, epidemiology, substance use, telepsychiatry and sleep disorders. He has also served as reviewer and editorial board member for several scientific journals. Disclosure: Ujjwal Ramtekkar, MD, MPE, MBA has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Instructor: Joshua Feder, MD
Dr. Joshua Feder is Director of Research, Graduate School, Interdisciplinary Council on Developmental and Learning Disorders, voluntary associate professor at UCSD School of Medicine, and medical director at SymPlay, teaching, advocating, and developing technology to support relationship-based interventions (joshuafedermd.com). Disclosure: Joshua Feder, MD discloses the following potential conflict of interests/commercial interests: Relevant Financial Relationship with Carlat Publishing as Editor in Chief Relevant Financial Relationship with Quicksilver Software as Medical Director Relevant Financial Relationship with Fielding Graduate as Adjunct Professor
Target Audience:
The target audience for this course is: Advanced level Marriage and Family Therapists; Advanced level Professional Counselors; Advanced level Social Workers; Entry level Psychologists; Nurses; in the following settings: Health and Human Services.
Relias will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Course Delivery Method and Format
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Accommodations
If you require special accommodations to complete this module, please contact Relias Customer Support here.